- Home
- HUGE
as 07-26-2024 4:00pm EST
FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.
| Founded: | 1998 | Country: | Canada |
| Employees: | N/A | City: | N/A |
| Market Cap: | 7.8M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 2.7M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.19 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.13 - $1.68 | Next Earning Date: | 09-12-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest FSD Pharma Inc. Class B Subordinate Voting Shares News
HUGE Breaking Stock News: Dive into HUGE Ticker-Specific Updates for Smart Investing
Newsfile
a day ago
24/7 Market News Publishes Report Covering Functional Beverage Market, Featuring FSD Pharma
Newsfile
3 days ago
FSD Pharma Inc. Announces Results of Annual General and Special Meeting of Shareholders
Newsfile
3 days ago
24/7 Market News Publishes Report Covering Biotech Developments, Featuring FSD Pharma
Newsfile
22 days ago
FSD Pharma Files Amended and Restated Material Change Report
ACCESSWIRE
a month ago
FSD Pharma provides Corporate Update
MT Newswires
a month ago
Update: FSD Pharma $2 Million Arbitration Award Upheld by Federal Court Against Former CEO
MT Newswires
a month ago
Update: FSD Pharma $2 Million Arbitration Award Upheld by Federal Court Against Former CEO
MT Newswires
a month ago
FSD Pharma $2 Million Arbitration Award Upheld by Federal Court Against Former CEO
Compare HUGE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HUGE FSD Pharma Inc. Class B Subordinate Voting Shares - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.